SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Benchmarks for Value in Cancer Care: An Analysis of a Large Commercial Population
5 references·0 citing·26 second hop
Benchmarks for Value in Cancer Care: An Analysis of a Large Commercial Population (2011)Benchmarks for Value in Cancer Care: An A…Patient and Plan Characteristics Affecting Abandonment of Oral Oncolytic Prescriptions (2011)Patient and Plan Characterist…Cost Effectiveness of Evidence-Based Treatment Guidelines for the Treatment of Non–Small-Cell Lung Cancer in the Community Setting (2010)Cost Effectiveness of Evidenc…Cancer treatment cost in the United States (2010)Cancer treatment cost in the …American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care (2009)American Society of Clinical …Health Spending Projections Through 2015: Changes On The Horizon (2006)Health Spending Projections T…The Medical Expenditure Panel Survey: a national health information resource. (1997)Cost of Care for Elderly Cancer Patients in the United States (2008)Evaluation of Trends in the Cost of Initial Cancer Treatment (2008)Melanoma Treatment Costs (2012)The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, medicare, and medicaid (2012)Comparison of the Financial Burden of Survivors of Head and Neck Cancer With Other Cancer Survivors (2019)Net Health Benefits (1998)The Implications of Regional Variations in Medicare Spending. Part 1: The Content, Quality, and Accessibility of Care (2003)The Implications of Regional Variations in Medicare Spending. Part 2: Health Outcomes and Satisfaction with Care (2003)The State of Cancer Care in America, 2014: A Report by the American Society of Clinical Oncology (2014)Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011 (2015)An Arm and a Leg: The Rising Cost of Cancer Drugs and Impact on Access (2021)Celebrating the New (2008)Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study (2015)Financial toxicity and implications for cancer care in the era of molecular and immune therapies (2018)Financial Toxicity in Adults With Cancer: Adverse Outcomes and Noncompliance (2018)The Patient Protection and Affordable Care Act (2018)Medical Care Costs: How Much Welfare Loss? (1992)Estimating The Cost Of New Drug Development: Is It Really $802 Million? (2006)Association of Insurance with Cancer Care Utilization and Outcomes (2008)Risk Factors for Financial Hardship in Patients Receiving Adjuvant Chemotherapy for Colon Cancer: A Population-Based Exploratory Analysis (2012)For Working-Age Cancer Survivors, Medical Debt And Bankruptcy Create Financial Hardships (2016)Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies (2019)Health Spending Projections Through 2016: Modest Changes Obscure Part D's Impact (2007)Prescription Drugs And The Changing Concentration Of Health Care Expenditures (2007)The Grass is Not Always Greener: A Look at National Health Care Systems around the World (2008)
this work references cited by second hop

References

  • 2009American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care638 cited
  • 2011Patient and Plan Characteristics Affecting Abandonment of Oral Oncolytic Prescriptions249 cited
  • 2006Health Spending Projections Through 2015: Changes On The Horizon238 cited
  • 2010Cost Effectiveness of Evidence-Based Treatment Guidelines for the Treatment of Non–Small-Cell Lung Cancer in the Community Setting173 cited
  • 2010Cancer treatment cost in the United States156 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work